All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

News

Article

October 2, 2008

Pharmaceutical Technology

Pharmaceutical Technology-10-02-2008
Volume32
Issue 10

Trends: NAS Launches and NME Approvals Rise and Fall

A recent report shows a decline in NASs and a rise in NME applications in 2007.

Companies launched 25 new active substances (NAS) in 2007, a decline of 19% from the previous year, according to an August report from Parexel International. The consulting firm's US Drug Approval Trends and Yearbook 2008–2009 also reveals that only 16 new molecular entities (NMEs) were approved in the US during 2007. Yet the number of US-marketing applications filed for NMEs rose to 28 in 2007, a 33% increase from 2006.

(SHAKIROV/GETTY IMAGES)

"NME and NAS approvals are key measures of new-drug productivity in the biopharmaceutical industry, and these measures tend to improve based on the volume of new-drug submissions," said Mark Mathieu, director of publications at Parexel, in a press release. He called the recent increase in the number of NME submissions an encouraging sign.

In the press release, Mathieu also said Parexel's analysis shows that "record percentages of drug-marketing applications that the US Food and Drug Administration has designated as priority submissions are going straight to approval in the first review cycle."

Among the NMEs that FDA approved in 2007 were Novartis's (Basel) hypertension drug "Tekturna," GlaxoSmithKline's (London) breast-cancer treatment "Tykerb," and Merck's (Whitehouse Station, NJ) HIV treatment "Isentress."

Articles in this issue

i1-557185-1408660516248.jpg
Putting Together the Pieces
Integration the Easy Way
i1-557193-1408660480210.jpg
A Case for Developing a Standards-Based Approach to Plug-and-Play Equipment
i12_t-557187-1408660506342.gif
Effect of Binder Type and Binder Level on the Properties of Agglomerates Containing Lactose and Dibasic Calcium Phosphate Dihydrate
i15-557190-1408660491177.jpg
EC Reviews: An Executive Country Review on Turkey
i8_t-557196-1408660460889.jpg
Continuous Mixing of Solid Dosage Forms via Hot-Melt Extrusion

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Related Content
Advertisement
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
August 28th 2025

New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s

Patrick Falvey Georgia Sloboda Sarah DeDonder Lauren Schoukroun-Barnes
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 28th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Lung with tuberculosis, long covid or asthma disease, cancer cells, virus and air pollution, no tobacco day, organ donation | Image Credit: © Berit Kessler - stock.adobe.com
August 28th 2025

Cereno Scientific’s PAH Treatment Gets FDA Fast Track Status

Patrick Lavery
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
August 28th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Digital Transformation in Pharma Manufacturing: Industry Perspectives Survey
August 28th 2025

Digital Transformation in Pharma Manufacturing: Industry Perspectives Survey

Christopher Cole
A hand is placing the final wooden block with a green certificate checkmark, symbolizing achievement, quality assurance and completion, against a plain pastel blue background. | Image credit: TimmyTimTim – stock.adobe.com
August 28th 2025

Continued Process Verification Is Critical in Pharmaceutical Manufacturing

Philip Hoersch
Related Content
Advertisement
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
August 28th 2025

New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s

Patrick Falvey Georgia Sloboda Sarah DeDonder Lauren Schoukroun-Barnes
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 28th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Lung with tuberculosis, long covid or asthma disease, cancer cells, virus and air pollution, no tobacco day, organ donation | Image Credit: © Berit Kessler - stock.adobe.com
August 28th 2025

Cereno Scientific’s PAH Treatment Gets FDA Fast Track Status

Patrick Lavery
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail
August 28th 2025

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
Digital Transformation in Pharma Manufacturing: Industry Perspectives Survey
August 28th 2025

Digital Transformation in Pharma Manufacturing: Industry Perspectives Survey

Christopher Cole
A hand is placing the final wooden block with a green certificate checkmark, symbolizing achievement, quality assurance and completion, against a plain pastel blue background. | Image credit: TimmyTimTim – stock.adobe.com
August 28th 2025

Continued Process Verification Is Critical in Pharmaceutical Manufacturing

Philip Hoersch
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.